In recent years, the focus has shifted to proteins that can trigger cancer and can hence be targeted as potential treatment avenues. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukemia. The Cell Division and Cancer Group at the Spanish National Cancer Research Centre (CNIO), led by Marcos Malumbres, has discovered the molecular mechanism ...Sunday 12 October 2014
Study: 2 Oncogenes Linked With the Aggressiveness and Incidence of Leukemia in Mice
In recent years, the focus has shifted to proteins that can trigger cancer and can hence be targeted as potential treatment avenues. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukemia. The Cell Division and Cancer Group at the Spanish National Cancer Research Centre (CNIO), led by Marcos Malumbres, has discovered the molecular mechanism ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment